Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release

Nanomedicine

Volumn 8, Issue 8, 2013, Pages 1271-1280

  Aryal, Santosh ^a,b   Hu, Che Ming J ^a,b   Fang, Ronnie H ^a,b   Dehaini, Diana ^a   Carpenter, Cody ^a   Zhang, Dong Er ^b   Zhang, Liangfang ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

biomimetic nanoparticle; drug delivery; nanomedicine; polymeric nanoparticle; red blood cell membrane; sustained release

Indexed keywords

DOXORUBICIN; NANOPARTICLE; POLYMER;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG STABILITY; ERYTHROCYTE MEMBRANE; IN VITRO STUDY; MALE; MOUSE; NANOENCAPSULATION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; RING OPENING; SUSTAINED DRUG RELEASE;

CELL LINE, TUMOR; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; ERYTHROCYTE MEMBRANE; HUMANS; LEUKEMIA, MYELOID, ACUTE; NANOPARTICLES; POLYMERS;

EID: 84888274068     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.153     Document Type: Article

References (37)

1. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7(9), 771-782 (2008
2. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9(8), 615-627 (2010
3. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12), 751-760 (2007
4. Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano 3(1), 16-20 (2009
5. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5(4), 505-515 (2008
6. Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: Pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. Engl. 49(36), 6288-6308 (2010
7. Geng Y, Dalhaimer P, Cai S et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2(4), 249-255 (2007
8. Yoo JW, Chambers E, Mitragotri S. Factors that control the circulation time of nanoparticles in blood: Challenges, solutions and future prospects. Curr. Pharm. Design 16(21), 2298-2307 (2010
9. Hu CM, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA 108(27), 10980-10985 (2011
10. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 100, 119-130 (1963
11. Aryal S, Hu CM, Zhang L. Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol. Pharm. 8(4), 1401-1407 (2011
12. Tong R, Cheng J. Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles. J. Am. Chem. Soc. 131(13), 4744-4754 (2009
13. Aryal S, Hu CM, Zhang L. Polymer-cisplatin conjugate nanoparticles for acid-responsive drug delivery. ACS Nano 4(1), 251-258 (2010
14. Popielarski SR, Pun SH, Davis ME. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization. Bioconjug. Chem. 16(5), 1063-1070 (2005
15. Fang RH, Aryal S, Hu CM, Zhang L. Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir 26(22), 16958-16962 (2010
16. Tong R, Cheng J. Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates. Bioconjug. Chem. 21(1), 111-121 (2010
17. Gao W, Chan JM, Farokhzad OC. pH-responsive nanoparticles for drug delivery. Mol. Pharm. 7(6), 1913-1920 (2010
18. Gu F, Zhang L, Teply BA et al. Precise engineering of targeted nanoparticles by using self-Assembled biointegrated block copolymers. Proc. Natl Acad. Sci. USA 105(7), 2586-2591 (2008
19. Takae S, Miyata K, Oba M et al. PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. J. Am. Chem. Soc. 130(18), 6001-6009 (2008
20. Zhang L, Chan JM, Gu FX et al. Self-Assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform. ACS Nano 2(8), 1696-1702 (2008
21. Pornpattananangkul D, Zhang L, Olson S et al. Bacterial toxin-Triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J. Am. Chem. Soc. 133(11), 4132-4139 (2011
22. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release 79(1-3), 123-135 (2002
23. Li J, Jiang G, Ding F. The effect of pH on the polymer degradation and drug release from PLGA-mPEG microparticles. J. Appl. Polym. Sci. 109(1), 475-482 (2008
24. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 50, 874-875 (1961
25. Siepmann J, Peppas NA. Higuchi equation: Derivation, applications, use and misuse. Int. J. Pharm. 418(1), 6-12 (2011
26. Budhian A, Siegel SJ, Winey KI. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int. J. Pharm. 346(1-2), 151-159 (2008
27. Pitt CG, Schindler A. The kinetics of drug cleavage and release from matrices containing covalent polymer-drug conjugates. J. Control. Release 33(3), 391-395 (1995
28. Lowenberg B, Ossenkoppele GJ, van Putten W et al. High-dose daunorubicin in older patients with acute myeloid leukemia. N. Engl. J. Med. 361(13), 1235-1248 (2009
29. Hu C-MJ, Zhang L. Therapeutic nanoparticles to combat cancer drug resistance. Curr. Drug Metab. 10(8), 836-841 (2009
30. Ayen WY, Garkhal K, Kumar N. Doxorubicin-loaded (PEG)3-PLA nanopolymersomes: Effect of solvents and process parameters on formulation development and in vitro study. Mol. Pharm. 8(2), 466-478 (2011
31. Yoo HS, Park TG. Folate-receptor-Targeted delivery of doxorubicin nano-Aggregates stabilized by doxorubicin-PEG-folate conjugate. J. Control. Release 100(2), 247-256 (2004
32. Huwyler J, Cerletti A, Fricker G, Eberle AN, Drewe J. By-passing of P-glycoprotein using immunoliposomes. J. Drug Target. 10(1), 73-79 (2002
33. Rapoport N, Marin A, Luo Y, Prestwich GD, Muniruzzaman M. Intracellular uptake and trafficking of pluronic micelles in drug-sensitive and MDR cells: Effect on the intracellular drug localization. J. Pharm. Sci. 91(1), 157-170 (2002
34. Sahoo SK, Labhasetwar V. Enhanced anti proliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharm. 2(5), 373-383 (2005
35. Dordal MS, Jackson-Stone M, Ho AC, Winter JN, Atkinson AJ. Decreased intracellular compartmentalization of doxorubicin in cell lines expressing P-glycoprotein. J. Pharmacol. Exp. Ther. 271(3), 1286-1290 (1994
36. Mizutani M, Yamaguchi M, Miwa H et al. Frequent expression of MDR1 and MDR3 genes in acute myelocytic leukemia cells with t(8;21) (q22;q22). Int. J. Oncol. 10(3), 473-479 (1997
37. Rao J, Xu Dr, Zheng Fm et al. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells. J. Transl. Med. 9, 71 (2011